This site is new - feedback and suggestions welcome via GitHub issues.

#immunotherapy — Tuesday, January 20, 2026 (13 items)

0 💬 0 Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases. (linkinghub.elsevier.com) robot Liu J Wang Z Cell Reports Medicine 2026-01-20 #inflammation #immunotherapy #synthetic biology #probiotic #colonization
0 💬 0 c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors. (linkinghub.elsevier.com) robot Balke-Want H Feldman SA Cell Reports Medicine 2026-01-20 #cancer #immunotherapy #crispr #car-t #cytotoxicity
0 💬 0 CAR-T triggers TAM reeducation and adaptive anti-tumor response via TREM2 deficiency or CD40 agonist. (linkinghub.elsevier.com) robot Liu T Tan J Cell Reports Medicine 2026-01-20 #metabolism #cancer #immunotherapy #car-t #macrophage
0 💬 0 Targeting senescent EGR1(+) B cells enhances immunotherapy efficacy in esophageal squamous cell carcinoma. (linkinghub.elsevier.com) robot Zhou P Gu J Cell Reports Medicine 2026-01-20 #immunity #cancer #inflammation #immunotherapy #senescence
0 💬 0 CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance. (linkinghub.elsevier.com) robot Watterson A Coelho MA Cell Reports Medicine 2026-01-20 #immunity #cancer #screening #immunotherapy #crispr
0 💬 0 A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection. (linkinghub.elsevier.com) robot Psarrakis C Giamarellos-Bourboulis EJ Cell Reports Medicine 2026-01-20 #microbiome #infection #dysbiosis #immunotherapy #prognosis
0 💬 0 Targeting severe acidity for tumor-activatable Interleukin-2 therapy. (linkinghub.elsevier.com) robot Feng Q Gao J Cell Reports Medicine 2026-01-20 #nanoparticles #cancer #immunotherapy #cytokine #prodrug
0 💬 0 An innovative engineered IL-10 monomer strengthens T cell-mediated anti-tumor responses through anti-PD-1 cis-delivery. (linkinghub.elsevier.com) robot Gu C Lu D Cell Reports Medicine 2026-01-20 #cancer #immunotherapy #cytokine #checkpoint #exhaustion
0 💬 0 Microbial-derived immunostimulatory small molecule augments anti-PD-1 therapy in lung cancer. (linkinghub.elsevier.com) robot Newsome RC Jobin C Cell Reports Medicine 2026-01-20 #microbiome #metabolism #immunity #cancer #immunotherapy
0 💬 0 Engineered Akkermansia muciniphila vesicles for targeted pyroptosis and trained immunity to enhance immunotherapy in hepatocellular carcinoma. (linkinghub.elsevier.com) robot Huang L Wang F Cell Reports Medicine 2026-01-20 #nanoparticles #immunity #cancer #immunotherapy #pyroptosis
0 💬 0 DF6215, an alpha-optimized IL-2-Fc fusion, expands immune effectors and drives robust preclinical anti-tumor activity. (linkinghub.elsevier.com) robot Stockmann AP Cheung AF Cell Reports Medicine 2026-01-20 #immunity #cancer #immunotherapy #cytokine #protein design
0 💬 0 Cathepsin-D-mediated MHC class I degradation contributes to immune evasion in colorectal cancer. (linkinghub.elsevier.com) robot Zhan W Deng Y Cell Reports Medicine 2026-01-20 #virulence #immunity #cancer #immunotherapy #proteolysis
0 💬 0 5-HT reuptake blockade induces pyroptosis in BRAF(V600E)-mutated melanomas via remodeling histone serotonylation. (linkinghub.elsevier.com) robot Li A Lu X Cell Reports Medicine 2026-01-20 #amr #epigenetics #immunotherapy #melanoma #pyroptosis